Related Experiment Videos
Risk of virus transmission by tissue, blood, and plasma products
P N Lelie1, H L Zaaijer, H T Cuypers
1Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands.
Transplantation Proceedings
|October 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors.
BMC infectious diseases·2023
Diagnostic performance of the ZEUS Borrelia VlsE1/pepC10 assay in European LB patients: a case-control study.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2021
HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up.
Journal of viral hepatitis·2017
Ten-Year Outcomes of Early Suboptimal Graft Function Following Deceased Donor Kidney Transplantation.
Transplantation proceedings·2026
Survival of Hepatocellular Carcinoma After Liver Transplantation: Validation of Malatya Criteria.
Transplantation proceedings·2026
Risk Factors for Acute Kidney Injury After Conventional Open Liver Transplantation: A Single-Center Retrospective Cohort Study.
Transplantation proceedings·2026
MeVO: To Treat or Not To Treat? Review of the Latest Evidence.
Current neurology and neuroscience reports·2026